Project Grant 2348543
Award Date
3/15/24
Completion Date
2/28/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
West Lafayette, IN, USA
Similar Awards
This Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $275,000 to Perceptra Technologies, Inc. to demonstrate the technical feasibility of an integrated photonic Raman spectrometer for on-demand and real-time chemical analysis. The project aims to develop a compact, low-cost Raman sensor system that can provide reliable chemical measurements, addressing the current...
This $274,990 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel optical method for detecting microscopic tumors to enable more rapid and accurate point-of-care cancer diagnoses. The project aims to integrate plasmonic nanobubble sensors into a medical device platform and endoscope to perform minimally invasive, non-invasive cancer diagnostic procedures. The key product being...
This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program supports the development of a label-free, high-resolution, high-throughput protein screening platform called Vibrational Spectroscopy with Metasurface Optics (VISMO). The technology aims to enable simultaneous, minute-scale measurement of millions of protein samples, which would dramatically improve the lengthy and costly cycles...
The National Science Foundation awarded a $275,000 Project Grant to Oraliva, Inc. under the Technology, Innovation, and Partnerships program to develop a portable, programmable single cell cytology platform for the early detection of epithelial cancers. The platform will combine microfluidics and artificial intelligence to classify potentially cancerous tissue in near real-time through multiparameter single-cell analysis and automated evaluation. The objectives are to link different clinical...
This $449,996 federal Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop a highly sensitive, low-cost sensor platform to detect circulating tumor DNA (ctDNA) - a key biomarker for early cancer diagnosis, particularly in non-small cell lung cancer. Researchers at the University of Minnesota, in collaboration with the University of Cambridge, are combining microwave photonics and polymer-based micro-ring resonator technology to create...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
The National Science Foundation (NSF) awarded a $650,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of Illinois for the development of a bioinspired multispectral imaging sensor to support real-time intraoperative detection of cancer. The award aims to create a novel sensor that integrates perovskite nanocrystals and optical metasurfaces to simultaneously detect endogenous cancer biomarkers in the UV spectrum and exogenous markers...
This $305,000 National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Innovation Research (SBIR) award supports the development of an innovative breast cancer screening technology by Bired Imaging Inc., a for-profit organization located in Rochester, NY. The project aims to improve early detection of breast cancer, especially in women with dense breast tissue, by using infrared imaging and physics-based AI algorithms to detect malignant...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,362 provides funding to RT Microdx Inc., a minority-owned small business, to develop a novel molecular diagnostic platform for detecting respiratory diseases like strep throat. The platform aims to enable rapid, reliable, and affordable at-home pathogen detection without requiring an expensive tabletop device. The anticipated technical outcomes include a disposable,...